Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Shanghai Lymphoma Clinical Cohort

NCT07285174 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT07285174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Shanghai Lymphoma Clinical Cohort
Lead sponsor
Ruijin Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
December 18, 2025
Completion date
December 31, 2029
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cohort, lymphoma